Performance Data

Below are key performance indicators (KPIs) for each of our four focus areas (Access to Health, Employees, Environmental Sustainability, and Ethics & Values), as well as links to the performance data tables found throughout this site.

These KPIs serve as baseline measurements for our corporate responsibility activities, are measured globally unless otherwise noted, and cover all of our business units with the exception of joint ventures.

Access to Health

Key performance indicators (KPIs)

Discovery and invention20152016201720182019
Percentage of top 20 global burdens of disease addressed by our products and pipeline1, 288%88%88%88%100%
Narrative of our R&D investments in infectious diseases Infectious
Diseases
Number of established significant external licenses and collaborations6457556478
Good Clinical Practice/ Pharmacovigilance (GCP/PV) inspections by regulatory agencies of the company or clinical trial investigators, that led to significant fines, penalties, warning letters or product seizures0 0 0 0
Affordability20152016201720182019
Percentage of sold units recalled during a given year (recall rate globally)0.07%0.01%0.01%0.14%0.01%
Number of local and regional manufacturing partnerships to enable access179179153144144
Number of products available through local and regional partnerships1,157941765700630
New product and device registrations (annual)3, 4, 515614314312497
Products that have achieved WHO prequalification (cumulative)61111131313
Affordability20152016201720182019
Number of countries where dedicated affordability solutions have been initiatedNRNRNRNR40
Number of patents filed in low-income countries, as defined by The World Bank in its country and lending groups classifications (annual)NR NR NR NR 0
People reached globally through product donation and patient assistance programs and partnerships (in millions)7NRNRNRNR404
Strengthening systems and addressing inequity20152016201720182019
Annual investment in partnerships, programs, and impact investments that support health care capacity-building and address underlying barriers to access to health (in millions)8$21 $28$40$37$63
People reached through investment in partnerships, programs, and impact investment that support health care capacity-building and address underlying barriers to access to health (in millions)8188293311357422
Percentage of investment in partnerships and programs to strengthen health care capacity and address barriers to access, that is allocated to impact evaluationNRNRNRNR10%
Investment in patient- and provider-education programs (in millions)$80$80$90$115$102
Note: Unless otherwise stated, data for Access to Health are reflective of our Human Health business only; information on our company's Animal Health is reported separately.
NR: Not reported.
1As defined by the Institute for Health Metrics and Evaluation (IHME) using GBD 2017 data; excluding road injury, self-harm, interpersonal violence and neonatal disorders.
2This number is slightly higher in 2019 than in past years due to our expanded collaboration with MSD-Welcome Trust Hilleman Laboratories and our acquisitions of Immune Design and Peloton, Tilos Therapeutics and Calporta in 2019.
3Data includes new products and new indications.
4For information on new registrations by region, visit our Clinical Research section.
5Data for all years have been updated based on a tracking system upgrade that corrected miscounts in prior years.
6CRIXIVAN® (indinavir sulfate) was removed from our product list in 2019 and is no longer included in the total number of products that have achieved WHO prequalification.
7Estimate includes product donations through our Company’s Office of Corporate Responsibility and Patient Assistance Program.
8Includes investments by the Office of Corporate Responsibility, MSD for Mothers and/or our company's Foundation.

Employees

Key performance indicators (KPIs)

Diversity and inclusion20152016201720182019
Women in executive roles134%31%32%32%36%
Women on the Board21%23%23%23%25%
Members of underrepresented ethnic groups on the Board21%23%23%23%25%
Members of underrepresented ethnic groups in executive roles (U.S.)20%23%23%21%26%
Members of underrepresented ethnic groups in the workforce (U.S.)26%26%26%27%29%
Wellbeing20152016201720182019
Response rate to the Voice SurveyNA85%NA86%NA
Lost-time incident rate (LTIR)0.220.130.130.100.11
Recordable injury rate (RIR)0.480.350.330.300.30
Volunteerism20152016201720182019
Employees who took release time according to the global policy on employee volunteerism29.0%21.0%7.0%7.0%11.0%
Total recorded volunteer hours380,585214,862114,903114,393136,014
NA: Not available.
1“Executive” is defined as the chief executive officer and two structural levels below.
2Where specific data is not available, data has been estimated.
32017 figures are based on employee self-recorded volunteer hours and volunteer hours communicated directly to the Office of Corporate Responsibility for certain countries. 2015 marked the first year in which volunteer hour reporting was based solely on employee self-reporting. Prior years included estimates for unrecorded volunteer hours.

Environmental Sustainability

Key performance indicators (KPIs)1

Sustainability summary20152016201720182019
Greenhouse gas emissions (Scope 1 & location-based Scope 2) (MT CO2e)11,416,9001,365,0001,258,9001,225,6001,168,900
Water usage (million m3)24.020.719.620.520.3
Operational waste generated (MT)69,85672,59972,42673,93075,500
1In accordance with the Greenhouse Gas Protocol, prior-year data have been adjusted to add or remove facilities that have been acquired or sold. Adjustments also reflect changes in methodology to ensure consistency from year to year.

Ethics & Values

Key performance indicators (KPIs)

Code of conduct20132014201520162017
Employees trained on our code of conduct99%100%100%99%99%

Economic Impact

Performance data